Cargando…

INO-4800 DNA vaccine induces neutralizing antibodies and T cell activity against global SARS-CoV-2 variants

Global surveillance has identified emerging SARS-CoV-2 variants of concern (VOC) associated with broadened host specificity, pathogenicity, and immune evasion to vaccine-induced immunity. Here we compared humoral and cellular responses against SARS-CoV-2 VOC in subjects immunized with the DNA vaccin...

Descripción completa

Detalles Bibliográficos
Autores principales: Andrade, Viviane M., Christensen-Quick, Aaron, Agnes, Joseph, Tur, Jared, Reed, Charles, Kalia, Richa, Marrero, Idania, Elwood, Dustin, Schultheis, Katherine, Purwar, Mansi, Reuschel, Emma, McMullan, Trevor, Pezzoli, Patrick, Kraynyak, Kim, Sylvester, Albert, Mammen, Mammen P., Tebas, Pablo, Joseph Kim, J., Weiner, David B., Smith, Trevor R. F., Ramos, Stephanie J., Humeau, Laurent M., Boyer, Jean D., Broderick, Kate E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516974/
https://www.ncbi.nlm.nih.gov/pubmed/34650089
http://dx.doi.org/10.1038/s41541-021-00384-7
_version_ 1784583912632090624
author Andrade, Viviane M.
Christensen-Quick, Aaron
Agnes, Joseph
Tur, Jared
Reed, Charles
Kalia, Richa
Marrero, Idania
Elwood, Dustin
Schultheis, Katherine
Purwar, Mansi
Reuschel, Emma
McMullan, Trevor
Pezzoli, Patrick
Kraynyak, Kim
Sylvester, Albert
Mammen, Mammen P.
Tebas, Pablo
Joseph Kim, J.
Weiner, David B.
Smith, Trevor R. F.
Ramos, Stephanie J.
Humeau, Laurent M.
Boyer, Jean D.
Broderick, Kate E.
author_facet Andrade, Viviane M.
Christensen-Quick, Aaron
Agnes, Joseph
Tur, Jared
Reed, Charles
Kalia, Richa
Marrero, Idania
Elwood, Dustin
Schultheis, Katherine
Purwar, Mansi
Reuschel, Emma
McMullan, Trevor
Pezzoli, Patrick
Kraynyak, Kim
Sylvester, Albert
Mammen, Mammen P.
Tebas, Pablo
Joseph Kim, J.
Weiner, David B.
Smith, Trevor R. F.
Ramos, Stephanie J.
Humeau, Laurent M.
Boyer, Jean D.
Broderick, Kate E.
author_sort Andrade, Viviane M.
collection PubMed
description Global surveillance has identified emerging SARS-CoV-2 variants of concern (VOC) associated with broadened host specificity, pathogenicity, and immune evasion to vaccine-induced immunity. Here we compared humoral and cellular responses against SARS-CoV-2 VOC in subjects immunized with the DNA vaccine, INO-4800. INO-4800 vaccination induced neutralizing antibodies against all variants tested, with reduced levels detected against B.1.351. IFNγ T cell responses were fully maintained against all variants tested.
format Online
Article
Text
id pubmed-8516974
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-85169742021-10-29 INO-4800 DNA vaccine induces neutralizing antibodies and T cell activity against global SARS-CoV-2 variants Andrade, Viviane M. Christensen-Quick, Aaron Agnes, Joseph Tur, Jared Reed, Charles Kalia, Richa Marrero, Idania Elwood, Dustin Schultheis, Katherine Purwar, Mansi Reuschel, Emma McMullan, Trevor Pezzoli, Patrick Kraynyak, Kim Sylvester, Albert Mammen, Mammen P. Tebas, Pablo Joseph Kim, J. Weiner, David B. Smith, Trevor R. F. Ramos, Stephanie J. Humeau, Laurent M. Boyer, Jean D. Broderick, Kate E. NPJ Vaccines Brief Communication Global surveillance has identified emerging SARS-CoV-2 variants of concern (VOC) associated with broadened host specificity, pathogenicity, and immune evasion to vaccine-induced immunity. Here we compared humoral and cellular responses against SARS-CoV-2 VOC in subjects immunized with the DNA vaccine, INO-4800. INO-4800 vaccination induced neutralizing antibodies against all variants tested, with reduced levels detected against B.1.351. IFNγ T cell responses were fully maintained against all variants tested. Nature Publishing Group UK 2021-10-14 /pmc/articles/PMC8516974/ /pubmed/34650089 http://dx.doi.org/10.1038/s41541-021-00384-7 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Brief Communication
Andrade, Viviane M.
Christensen-Quick, Aaron
Agnes, Joseph
Tur, Jared
Reed, Charles
Kalia, Richa
Marrero, Idania
Elwood, Dustin
Schultheis, Katherine
Purwar, Mansi
Reuschel, Emma
McMullan, Trevor
Pezzoli, Patrick
Kraynyak, Kim
Sylvester, Albert
Mammen, Mammen P.
Tebas, Pablo
Joseph Kim, J.
Weiner, David B.
Smith, Trevor R. F.
Ramos, Stephanie J.
Humeau, Laurent M.
Boyer, Jean D.
Broderick, Kate E.
INO-4800 DNA vaccine induces neutralizing antibodies and T cell activity against global SARS-CoV-2 variants
title INO-4800 DNA vaccine induces neutralizing antibodies and T cell activity against global SARS-CoV-2 variants
title_full INO-4800 DNA vaccine induces neutralizing antibodies and T cell activity against global SARS-CoV-2 variants
title_fullStr INO-4800 DNA vaccine induces neutralizing antibodies and T cell activity against global SARS-CoV-2 variants
title_full_unstemmed INO-4800 DNA vaccine induces neutralizing antibodies and T cell activity against global SARS-CoV-2 variants
title_short INO-4800 DNA vaccine induces neutralizing antibodies and T cell activity against global SARS-CoV-2 variants
title_sort ino-4800 dna vaccine induces neutralizing antibodies and t cell activity against global sars-cov-2 variants
topic Brief Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516974/
https://www.ncbi.nlm.nih.gov/pubmed/34650089
http://dx.doi.org/10.1038/s41541-021-00384-7
work_keys_str_mv AT andradevivianem ino4800dnavaccineinducesneutralizingantibodiesandtcellactivityagainstglobalsarscov2variants
AT christensenquickaaron ino4800dnavaccineinducesneutralizingantibodiesandtcellactivityagainstglobalsarscov2variants
AT agnesjoseph ino4800dnavaccineinducesneutralizingantibodiesandtcellactivityagainstglobalsarscov2variants
AT turjared ino4800dnavaccineinducesneutralizingantibodiesandtcellactivityagainstglobalsarscov2variants
AT reedcharles ino4800dnavaccineinducesneutralizingantibodiesandtcellactivityagainstglobalsarscov2variants
AT kaliaricha ino4800dnavaccineinducesneutralizingantibodiesandtcellactivityagainstglobalsarscov2variants
AT marreroidania ino4800dnavaccineinducesneutralizingantibodiesandtcellactivityagainstglobalsarscov2variants
AT elwooddustin ino4800dnavaccineinducesneutralizingantibodiesandtcellactivityagainstglobalsarscov2variants
AT schultheiskatherine ino4800dnavaccineinducesneutralizingantibodiesandtcellactivityagainstglobalsarscov2variants
AT purwarmansi ino4800dnavaccineinducesneutralizingantibodiesandtcellactivityagainstglobalsarscov2variants
AT reuschelemma ino4800dnavaccineinducesneutralizingantibodiesandtcellactivityagainstglobalsarscov2variants
AT mcmullantrevor ino4800dnavaccineinducesneutralizingantibodiesandtcellactivityagainstglobalsarscov2variants
AT pezzolipatrick ino4800dnavaccineinducesneutralizingantibodiesandtcellactivityagainstglobalsarscov2variants
AT kraynyakkim ino4800dnavaccineinducesneutralizingantibodiesandtcellactivityagainstglobalsarscov2variants
AT sylvesteralbert ino4800dnavaccineinducesneutralizingantibodiesandtcellactivityagainstglobalsarscov2variants
AT mammenmammenp ino4800dnavaccineinducesneutralizingantibodiesandtcellactivityagainstglobalsarscov2variants
AT tebaspablo ino4800dnavaccineinducesneutralizingantibodiesandtcellactivityagainstglobalsarscov2variants
AT josephkimj ino4800dnavaccineinducesneutralizingantibodiesandtcellactivityagainstglobalsarscov2variants
AT weinerdavidb ino4800dnavaccineinducesneutralizingantibodiesandtcellactivityagainstglobalsarscov2variants
AT smithtrevorrf ino4800dnavaccineinducesneutralizingantibodiesandtcellactivityagainstglobalsarscov2variants
AT ramosstephaniej ino4800dnavaccineinducesneutralizingantibodiesandtcellactivityagainstglobalsarscov2variants
AT humeaulaurentm ino4800dnavaccineinducesneutralizingantibodiesandtcellactivityagainstglobalsarscov2variants
AT boyerjeand ino4800dnavaccineinducesneutralizingantibodiesandtcellactivityagainstglobalsarscov2variants
AT broderickkatee ino4800dnavaccineinducesneutralizingantibodiesandtcellactivityagainstglobalsarscov2variants